Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Avacta Life Sciences Ltd
Pfizer
Seagen Inc.
National Institutes of Health Clinical Center (CC)
Kivu Bioscience Inc.
University Health Network, Toronto
BeOne Medicines
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Eli Lilly and Company
Novartis
NiKang Therapeutics, Inc.
MacroGenics
Amgen
SystImmune Inc.
Centre Antoine Lacassagne
SciTech Development, Inc.
Amgen
Nerviano Medical Sciences
Boehringer Ingelheim
Memorial Sloan Kettering Cancer Center
Janux Therapeutics
Sichuan Baili Pharmaceutical Co., Ltd.
Novelty Nobility, Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Chipscreen Biosciences, Ltd.
CSPC Megalith Biopharmaceutical Co.,Ltd.
Innovent Biologics (Suzhou) Co. Ltd.